Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
Key facts
- Who runs it
- Northwell Health
- Where
- New York, Poplar Bluff, and Staten Island, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 13 people enrolled
- Started
- 4 May 2021
- Ended
- 26 Feb 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Batten batten graft
- Septoplasty
- Inferior Turbinate Reduction
- Record updated
- 13 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Patients should satisfy all the following criteria to be considered eligible for randomization:; Be age 18 or above; Able to provide written informed consent; Have an indication for batten graft, septoplasty and turbinate reduction according to prevailing surgical practices; <!-- -->; Septal deviation must be present on direct or endoscopic examination; Inferior turbinate hypertrophy must be present, direct examination or endoscopic examination; Collapse of external nasal valve and/or lateral motion instability must be documented; <!-- -->; The ENV maye be assessed clinically by observing the alar collapse at baseline or with forced inspiration, Modified cottle may also be performed; In all patients, endoscopic examination should document that the (a) septal deviation, (b) turbinate hypertrophy, and (c) external nasal valve collapse are the primary contributing factors of obstructed breathing
Who cannot take part
- History of previous functional rhinoplasty or sinus or septal surgery
- Patients who are selected for concurrent aesthetic/cosmetic rhinoplasty
- Patients who have concurrent sinus surgery or polyp removal or concha bullosa resection
- Septal perforation
- Untreated allergic rhinitis or allergic rhinitis unresponsive to medical management
Where in United States
- Lenox Hill Hospital/Staten Island University HospitalNew York, United States
- Poplar Bluff Regional Medical CenterPoplar Bluff, United States
- Staten Island University HospitalStaten Island, United States
About the trial
What the trial wants to find out
The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
The 2 groups in the trial
- Batten graft, plus septoplasty and inferior turbinate reductionTreatment being tested
In the intervention arm, a portion of the quadrangular cartilage of the nasal septum is also removed, but will be refashioned and re-implanted into the patient as an autologous batten graft. This will be performed together with standard septoplasty and turbinate reduction.
Treatment: Batten batten graft, Septoplasty, and Inferior Turbinate Reduction
- Septoplasty and inferior turbinate reduction aloneExisting treatment, for comparison
In the control arm, a portion of the quadrangular cartilage of the nasal septum is removed. This will be performed as a standard septoplasty and turbinate reduction.
Treatment: Septoplasty and Inferior Turbinate Reduction
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Does the Addition of Batten Grafting Improve Nasal Outcomes in Patients Undergoing Septoplasty and Turbinate Reduction? A Pragmatic Randomized Controlled Trial
- Record updated
- 13 October 2026